TUMORANTIGENPEPTID

Patent europeic · EP3231867 · Stritgà

Inscripziun en il register

Numer da publicaziun: EP3231867
Numer da la dumonda: EP15867698
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: Stritgà
Scrittira da patent: Concedì
Annunzià: 08-12-2015
Publitgà: 18-10-2017
Concedì: 14-09-2022
Stritgà: 25-07-2023
Motiv: Taxa annuala betg pajada
Classas IPC: C12N 15/09 (2006.01)
A61K 39/00 (2006.01)
A61K 48/00 (2006.01)
A61P 35/00 (2006.01)
C07K 7/06 (2006.01)
C07K 16/30 (2006.01)
C12Q 1/68 (2018.01)
G01N 33/15 (2006.01)
G01N 33/50 (2006.01)
G01N 33/574 (2006.01)
Prioritad: JP 2014249169 09.12.2014
Dumonda PCT: PCT/JP2015/084428 08.12.2015
Publicaziun PCT: WO2016/093243 16.06.2016
Lingua da l’annunzia: giapunais
Funtauna: Swissreg

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

26-07-2023
Midada
Published in Swissreg on 26.07.2023
25-07-2023
Stritgà, taxa betg pajada
Published in Swissreg on 25.07.2023
07-03-2023
Owner
Owner
Sumitomo Pharma Co., Ltd., 6-8, Doshomachi 2-chome, Chuo-ku,, Osaka-shi,, Osaka 541-0045, Japan, Sapporo Medical University, 291-85, Minami 1-jo, Nishi 17-chome, Chuo-ku, Sapporo-shi, Hokkaido 060-8556, Japan → Sapporo Medical University, 291-85, Minami 1-jo, Nishi 17-chome, Chuo-ku, Sapporo-shi, Hokkaido 060-8556, Japan, Association for Kokichi Kikuchi memorial, academic promotion, 1-10-1101, Kita4-jo Nishi 22-chome, Chuo-ku, Sapporo-shi, Hokkaido 0640824, Japan
Published in Swissreg on 07.03.2023
14-09-2022
Concedì
Published in Swissreg on 14.09.2022

291-85, Minami 1-jo Nishi 17-chome Chuo-ku, Sapporo-shi, Hokkaido 060-8556, JP

1-10-1101, Kita4-jo Nishi 22-chome Chuo-ku Sapporo-shi, Hokkaido 0640824, JP